Immuron Announces Positive Results of IMM-124E in Acute Colitis Research Program

Immuron Announces Positive Results of IMM-124E in Acute Colitis Research Program
Australia’s Immuron announced beneficial results of IMM-124E in acute models of colitis, including clinical parameters, tissue analysis, and immunological biomarkers. Colitis refers mainly to ulcerative colitis and Crohn’s disease, major categories of inflammatory bowel disease that affect millions of people worldwide. Current knowledge indicates that colitis results from complex interactions between the environment, genetic predisposition, immune

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *